Companies / Compass Therapeutics, Inc. / Activity
Activity — Compass Therapeutics, Inc.
18 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 8, 2026 | Schuetz Thomas J. CEO | Other | Common Stock | $239.2K | -37K -0.55% | 6,603,336 3.67% of shares | low |
| Jan 9, 2026 | Schuetz Thomas J. CEO | Other | Common Stock | $250.3K | -47K -0.70% | 6,640,023 3.69% of shares | low |
| Jan 2, 2026 | Lerner Neil Executive | Grant | Common Stock | $323.1K | +63K +19.53% | 382,500 0.21% of shares | low |
| Jan 2, 2026 | Shin Barry Executive | Grant | Common Stock | $646.3K | +125K +31.25% | 525,000 0.29% of shares | low |
| Jan 2, 2026 | Anderman Jonathan Executive | Grant | Common Stock | $775.5K | +150K +714.29% | 171,000 0.09% of shares | low |
| Jan 2, 2026 | Schuetz Thomas J. CEO | Grant | Common Stock | $1.29M | +250K +3.88% | 6,686,800 3.71% of shares | low |
| Jan 2, 2026 | Ferneau Philip Director | Grant | Stock Option (Right to Buy) | — | +90K | 90,000 0.05% of shares | low |
| Jan 2, 2026 | Sirard Cynthia Executive | Grant | STOCK OPTION (RIGHT TO BUY) | — | +1.0M | 1,000,000 0.56% of shares | low |
| Jan 2, 2026 | Shin Barry Executive | Grant | Stock Option (Right to Buy) | — | +670K | 670,000 0.37% of shares | low |
| Jan 2, 2026 | Schuetz Thomas J. CEO | Grant | Stock Option (Right to Buy) | — | +2.0M | 2,000,000 1.11% of shares | low |
| Jan 2, 2026 | Prasad Arjun Executive | Grant | STOCK OPTION (RIGHT TO BUY) | — | +1.0M | 1,000,000 0.56% of shares | low |
| Jan 2, 2026 | Lindahl Richard S Director | Grant | Stock Option (Right to Buy) | — | +90K | 90,000 0.05% of shares | low |
| Jan 2, 2026 | Chiniara Ellen Director | Grant | Stock Option (Right to Buy) | — | +90K | 90,000 0.05% of shares | low |
| Jan 2, 2026 | Lerner Neil Executive | Grant | Stock Option (Right to Buy) | — | +435K | 435,000 0.24% of shares | low |
| Jan 2, 2026 | Gray Mary Ann Director | Grant | Stock Option (Right to Buy) | — | +90K | 90,000 0.05% of shares | low |
| Jan 2, 2026 | Boylan James P Director | Grant | Stock Option (Right to Buy) | — | +90K | 90,000 0.05% of shares | low |
| Jan 2, 2026 | Gordon Carl L Director | Grant | Stock Option (Right to Buy) | — | +90K | 90,000 0.05% of shares | low |
| Jan 2, 2026 | Anderman Jonathan Executive | Grant | Stock Option (Right to Buy) | — | +720K | 720,000 0.40% of shares | low |